Advertisement

Index by author

June 01, 2019; Volume 47,Issue 6

  1. Sun, Dongli

    1. Maternal Plasma l-Carnitine Reduction During Pregnancy Is Mainly Attributed to OCTN2-Mediated Placental Uptake and Does Not Result in Maternal Hepatic Fatty Acid β-Oxidation Decline
      Mengru Bai, Qingquan Zeng, Yingchun Chen, Mingyang Chen, Ping Li, Zhiyuan Ma, Dongli Sun, Hui Zhou, Caihong Zheng, Su Zeng and Huidi Jiang
      Drug Metabolism and Disposition June 2019, 47 (6) 582-591; DOI: https://doi.org/10.1124/dmd.119.086439

  2. Takayama, Kazuo

    1. Modeling of Hepatic Drug Metabolism and Responses in CYP2C19 Poor Metabolizer Using Genetically Manipulated Human iPS cells
      Modeling of Hepatic Drug Metabolism and Responses in CYP2C19 Poor Metabolizer Using Genetically Manipulated Human iPS cells
      Sayaka Deguchi, Tomoki Yamashita, Keisuke Igai, Kazuo Harada, Yukiko Toba, Kazumasa Hirata, Kazuo Takayama and Hiroyuki Mizuguchi
      Drug Metabolism and Disposition June 2019, 47 (6) 632-638; DOI: https://doi.org/10.1124/dmd.119.086322

  3. Tan, Xian-Wen

    1. Stereoselective Oxidation Kinetics of Deoxycholate in Recombinant and Microsomal CYP3A Enzymes: Deoxycholate 19-Hydroxylation Is an In Vitro Marker of CYP3A7 Activity
      Yu-Jie Chen, Jian Zhang, Ping-Ping Zhu, Xian-Wen Tan, Qiu-Hong Lin, Wen-Xia Wang, Shan-Shan Yin, Ling-Zhi Gao, Ming-Ming Su, Chang-Xiao Liu, Liang Xu, Wei Jia, Irina F. Sevrioukova and Ke Lan
      Drug Metabolism and Disposition June 2019, 47 (6) 574-581; DOI: https://doi.org/10.1124/dmd.119.086637

  4. Tang, Chongzhuang

    1. Mechanism of Reductive Metabolism and Chiral Inversion of Proton Pump Inhibitors
      Chongzhuang Tang, Zhaoqiang Chen, Xiaojian Dai, Weiliang Zhu, Dafang Zhong and Xiaoyan Chen
      Drug Metabolism and Disposition June 2019, 47 (6) 657-664; DOI: https://doi.org/10.1124/dmd.118.086090

  5. Toba, Yukiko

    1. Modeling of Hepatic Drug Metabolism and Responses in CYP2C19 Poor Metabolizer Using Genetically Manipulated Human iPS cells
      Modeling of Hepatic Drug Metabolism and Responses in CYP2C19 Poor Metabolizer Using Genetically Manipulated Human iPS cells
      Sayaka Deguchi, Tomoki Yamashita, Keisuke Igai, Kazuo Harada, Yukiko Toba, Kazumasa Hirata, Kazuo Takayama and Hiroyuki Mizuguchi
      Drug Metabolism and Disposition June 2019, 47 (6) 632-638; DOI: https://doi.org/10.1124/dmd.119.086322

  6. Tod, Michel

    1. Prediction of Human Nonlinear Pharmacokinetics of a New Bcl-2 Inhibitor Using PBPK Modeling and Interspecies Extrapolation Strategy
      Philippe B. Pierrillas, Emilie Henin, Kathryn Ball, Julien Ogier, Magali Amiel, Laurence Kraus-Berthier, Marylore Chenel, François Bouzom and Michel Tod
      Drug Metabolism and Disposition June 2019, 47 (6) 648-656; DOI: https://doi.org/10.1124/dmd.118.085605

  7. Vyhlidal, Carrie A.

    1. Developmental Expression of the Cytosolic Sulfotransferases in Human Liver
      Sarah Dubaisi, Joseph A. Caruso, Roger Gaedigk, Carrie A. Vyhlidal, Philip C. Smith, Ronald N. Hines, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition June 2019, 47 (6) 592-600; DOI: https://doi.org/10.1124/dmd.119.086363

  8. Wang, Wen-Xia

    1. Stereoselective Oxidation Kinetics of Deoxycholate in Recombinant and Microsomal CYP3A Enzymes: Deoxycholate 19-Hydroxylation Is an In Vitro Marker of CYP3A7 Activity
      Yu-Jie Chen, Jian Zhang, Ping-Ping Zhu, Xian-Wen Tan, Qiu-Hong Lin, Wen-Xia Wang, Shan-Shan Yin, Ling-Zhi Gao, Ming-Ming Su, Chang-Xiao Liu, Liang Xu, Wei Jia, Irina F. Sevrioukova and Ke Lan
      Drug Metabolism and Disposition June 2019, 47 (6) 574-581; DOI: https://doi.org/10.1124/dmd.119.086637

  9. Wolf, C.R.

    1. Open Access
      An Extensively Humanized Mouse Model to Predict Pathways of Drug Disposition and Drug/Drug Interactions, and to Facilitate Design of Clinical Trials
      C.J. Henderson, Y. Kapelyukh, N. Scheer, A. Rode, AW. McLaren, A.K. MacLeod, D. Lin, J. Wright, L.A. Stanley and C.R. Wolf
      Drug Metabolism and Disposition June 2019, 47 (6) 601-615; DOI: https://doi.org/10.1124/dmd.119.086397

  10. Wright, J.

    1. Open Access
      An Extensively Humanized Mouse Model to Predict Pathways of Drug Disposition and Drug/Drug Interactions, and to Facilitate Design of Clinical Trials
      C.J. Henderson, Y. Kapelyukh, N. Scheer, A. Rode, AW. McLaren, A.K. MacLeod, D. Lin, J. Wright, L.A. Stanley and C.R. Wolf
      Drug Metabolism and Disposition June 2019, 47 (6) 601-615; DOI: https://doi.org/10.1124/dmd.119.086397
« Previous (Pages : 4 5 6 7 8 9 10 ... 10) Next »
Back to top

In this issue

Advertisement